Literature DB >> 24275715

Early colon screening of adult patients with cystic fibrosis reveals high incidence of adenomatous colon polyps.

Joanne L Billings1, Jordan M Dunitz, Sandra McAllister, Tyler Herzog, Aleh Bobr, Alexander Khoruts.   

Abstract

BACKGROUND AND GOALS: Cystic fibrosis (CF) is associated with increased incidence of gastrointestinal cancer. Increasing overall life expectancy of CF patients predicts emergence of colon cancer as a significant clinical problem in the adult CF population. The primary aim of this study was to estimate the incidence of adenomatous colon polyps in patients with CF during systematic screening by colonoscopy. STUDY: This is a single-center series of 45 CF patients aged 40 years and above (mean age, 47 y) undergoing colonoscopic screening. A fraction of these patients (9/45) had history of organ transplantation. Results from transplant and nontransplant patients were analyzed separately.
RESULTS: Adult CF patients have a high incidence of adenomatous polyps identified by colonoscopy. In addition, positive examinations are characterized by multiple polyps and common features of advanced pathology. The incidence of adenomatous colon polyps is greater in male patients, although the 1 patient in this cohort found to have colorectal cancer was female.
CONCLUSIONS: CF has features of a hereditary colon cancer syndrome. Increasing life expectancy of CF patients suggests that earlier colon screening in this population may be warranted. Optimal criteria for initiation of screening and frequency of surveillance should be subject of further studies.

Entities:  

Mesh:

Year:  2014        PMID: 24275715     DOI: 10.1097/MCG.0000000000000034

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  21 in total

Review 1.  The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.

Authors:  Millie Garg; Chee Y Ooi
Journal:  Curr Gastroenterol Rep       Date:  2017-02

2.  CFTR is a tumor suppressor gene in murine and human intestinal cancer.

Authors:  B L N Than; J F Linnekamp; T K Starr; D A Largaespada; A Rod; Y Zhang; V Bruner; J Abrahante; A Schumann; T Luczak; A Niemczyk; M G O'Sullivan; J P Medema; R J A Fijneman; G A Meijer; E Van den Broek; C A Hodges; P M Scott; L Vermeulen; R T Cormier
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

Review 3.  Cystic fibrosis: a clinical view.

Authors:  Carlo Castellani; Baroukh M Assael
Journal:  Cell Mol Life Sci       Date:  2016-10-05       Impact factor: 9.261

4.  Drosophila as a model for studying cystic fibrosis pathophysiology of the gastrointestinal system.

Authors:  Kevin Kim; Elizabeth A Lane; Aurelia Saftien; Haiyun Wang; Yue Xu; Frederik Wirtz-Peitz; Norbert Perrimon
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-28       Impact factor: 11.205

5.  Colonoscopic screening shows increased early incidence and progression of adenomas in cystic fibrosis.

Authors:  David E Niccum; Joanne L Billings; Jordan M Dunitz; Alexander Khoruts
Journal:  J Cyst Fibros       Date:  2016-02-02       Impact factor: 5.482

Review 6.  Cystic fibrosis from the gastroenterologist's perspective.

Authors:  Chee Y Ooi; Peter R Durie
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-01-21       Impact factor: 46.802

7.  The expression of Mirc1/Mir17-92 cluster in sputum samples correlates with pulmonary exacerbations in cystic fibrosis patients.

Authors:  Kathrin Krause; Benjamin T Kopp; Mia F Tazi; Kyle Caution; Kaitlin Hamilton; Asmaa Badr; Chandra Shrestha; Dmitry Tumin; Don Hayes; Frank Robledo-Avila; Luanne Hall-Stoodley; Brett G Klamer; Xiaoli Zhang; Santiago Partida-Sanchez; Narasimham L Parinandi; Stephen E Kirkby; Duaa Dakhlallah; Karen S McCoy; Estelle Cormet-Boyaka; Amal O Amer
Journal:  J Cyst Fibros       Date:  2017-12-11       Impact factor: 5.482

Review 8.  Mouse models for the discovery of colorectal cancer driver genes.

Authors:  Christopher R Clark; Timothy K Starr
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

9.  Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer.

Authors:  Andrea Gini; Ann G Zauber; Dayna R Cenin; Amir-Houshang Omidvari; Sarah E Hempstead; Aliza K Fink; Albert B Lowenfels; Iris Lansdorp-Vogelaar
Journal:  Gastroenterology       Date:  2017-11-02       Impact factor: 22.682

Review 10.  Cystic fibrosis transmembrane conductance regulator-emerging regulator of cancer.

Authors:  Jieting Zhang; Yan Wang; Xiaohua Jiang; Hsiao Chang Chan
Journal:  Cell Mol Life Sci       Date:  2018-02-06       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.